Cargando…

Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series

BACKGROUND: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. CASE SUMMARY: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashyap, Niharika, Nikhanj, Anish, Gagnon, Luke R, Moukaskas, Basel, Siddiqi, Zaeem A, Oudit, Gavin Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879840/
https://www.ncbi.nlm.nih.gov/pubmed/36727127
http://dx.doi.org/10.1093/ehjcr/ytad013
_version_ 1784878777273155584
author Kashyap, Niharika
Nikhanj, Anish
Gagnon, Luke R
Moukaskas, Basel
Siddiqi, Zaeem A
Oudit, Gavin Y
author_facet Kashyap, Niharika
Nikhanj, Anish
Gagnon, Luke R
Moukaskas, Basel
Siddiqi, Zaeem A
Oudit, Gavin Y
author_sort Kashyap, Niharika
collection PubMed
description BACKGROUND: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. CASE SUMMARY: This study closely followed four adult patients from the Neuromuscular Multidisciplinary Clinic (Alberta, Canada) that presented with X-linked recessive EDMD. Patients were assessed and managed on a case-by-case basis. Clinical status and cardiac function were assessed through clinical history, physical examination, and investigations (12-lead electrocardiogram, 24 hour Holter monitor, transthoracic echocardiogram, and plasma biomarkers). Conduction disease, requiring permanent pacemaker, was prevalent in all patients. With appropriate medical therapy over a median follow-up period five years the cardiac status was shown to have stabilized in all these patients. DISCUSSION: We demonstrate the presentation of arrhythmias, conduction abnormalities, and chamber dilation in adult patients with X-linked EDMD. Cardiac medications and pacemaker therapy are shown to prevent adverse outcomes from these complications. Patients with EDMD are expected to develop heart disease early and prior to the development of an overt neuromuscular phenotype. These patients should be closely monitored in a multidisciplinary setting for effective management to improve their clinical outcomes.
format Online
Article
Text
id pubmed-9879840
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98798402023-01-31 Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series Kashyap, Niharika Nikhanj, Anish Gagnon, Luke R Moukaskas, Basel Siddiqi, Zaeem A Oudit, Gavin Y Eur Heart J Case Rep Case Series BACKGROUND: Heart disease is an under-recognized cause of morbidity and mortality in patients with Emery-Dreifuss muscular dystrophy (EDMD). Arrhythmias and conduction delays are highly prevalent and given the rarity of this disease the patient care process remains poorly defined. CASE SUMMARY: This study closely followed four adult patients from the Neuromuscular Multidisciplinary Clinic (Alberta, Canada) that presented with X-linked recessive EDMD. Patients were assessed and managed on a case-by-case basis. Clinical status and cardiac function were assessed through clinical history, physical examination, and investigations (12-lead electrocardiogram, 24 hour Holter monitor, transthoracic echocardiogram, and plasma biomarkers). Conduction disease, requiring permanent pacemaker, was prevalent in all patients. With appropriate medical therapy over a median follow-up period five years the cardiac status was shown to have stabilized in all these patients. DISCUSSION: We demonstrate the presentation of arrhythmias, conduction abnormalities, and chamber dilation in adult patients with X-linked EDMD. Cardiac medications and pacemaker therapy are shown to prevent adverse outcomes from these complications. Patients with EDMD are expected to develop heart disease early and prior to the development of an overt neuromuscular phenotype. These patients should be closely monitored in a multidisciplinary setting for effective management to improve their clinical outcomes. Oxford University Press 2023-01-11 /pmc/articles/PMC9879840/ /pubmed/36727127 http://dx.doi.org/10.1093/ehjcr/ytad013 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Series
Kashyap, Niharika
Nikhanj, Anish
Gagnon, Luke R
Moukaskas, Basel
Siddiqi, Zaeem A
Oudit, Gavin Y
Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
title Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
title_full Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
title_fullStr Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
title_full_unstemmed Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
title_short Cardiac manifestations and clinical management of X-linked Emery-Dreifuss muscular dystrophy: a case series
title_sort cardiac manifestations and clinical management of x-linked emery-dreifuss muscular dystrophy: a case series
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879840/
https://www.ncbi.nlm.nih.gov/pubmed/36727127
http://dx.doi.org/10.1093/ehjcr/ytad013
work_keys_str_mv AT kashyapniharika cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries
AT nikhanjanish cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries
AT gagnonluker cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries
AT moukaskasbasel cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries
AT siddiqizaeema cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries
AT ouditgaviny cardiacmanifestationsandclinicalmanagementofxlinkedemerydreifussmusculardystrophyacaseseries